Cited by 509Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer Cells and Metastasis

Metabolic heterogeneity confers differences in melanoma metastatic potential

Open access
Tasdogan, Alpaslan, Faubert, Brandon, Ramesh, Vijayashree, Ubellacker, Jessalyn M., Shen, Bo, Solmonson, Ashley, Murphy, Malea M., Gu, Zhimin +9 more·2020·Nature

Abstract

Metastasis requires cancer cells to undergo metabolic changes that are poorly understood 1-3. Here we show that metabolic differences among melanoma cells confer differences in metastatic potential as a result of differences in the function of the MCT1 transporter. In vivo isotope tracing analysis in patient-derived xenografts revealed differences in nutrient handling between efficiently and inefficiently metastasizing melanomas, with circulating lactate being a more prominent source of tumour lactate in efficient metastasizers. Efficient metastasizers had higher levels of MCT1, and inhibition of MCT1 reduced lactate uptake. MCT1 inhibition had little effect on the growth of primary subcutaneous tumours, but resulted in depletion of circulating melanoma cells and reduced the metastatic disease burden in patient-derived xenografts and in mouse melanomas. In addition, inhibition of MCT1 suppressed the oxidative pentose phosphate pathway and increased levels of reactive oxygen species. Antioxidants blocked the effects of MCT1 inhibition on metastasis. MCT1 high and MCT1-/low cells from the same melanomas had similar capacities to form subcutaneous tumours, but MCT1 high cells formed more metastases after intravenous injection. Metabolic differences among cancer cells thus confer differences in metastatic potential as metastasizing cells depend on MCT1 to manage oxidative stress.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-019-1847-2

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intravenous infusion of 13C-lactate into human non-small-cell lung cancer patients and mice bearing patient-derived melanomas identified tumors with a propensity for future metastasis, which required MCT1-dependent lactate transport in the mice.

    “Intravenous infusion of 13C-lactate into human non-small-cell lung cancer patients and mice bearing patient-derived melanomas identified tumors with a propensity for future metastasis, which required MCT1-dependent lactate transport in the mice (58, 100).”

    From Metabolic reprogramming and cancer progression (2020) · cites this paper as [100]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tasdogan, A., Faubert, B., Ramesh, V., Ubellacker, J. M., Shen, B., Solmonson, A., Murphy, M. M., Gu, Z., Gu, W., Martin, M., Kasitinon, S. Y., Vandergriff, T., Mathews, T. P., Zhao, Z., Schadendorf, D., DeBerardinis, R. J., & Morrison, S. J.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Deutsches Konsortium für Translationale Krebsforschung (DE)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • DeBerardinis, Ralph J.
  • Morrison, Sean J.
Venue
Nature
Published
2019-12-18
Volume
577
Issue
7788
Pages
115-120
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2995147378
Cited by
509
References
43
Citations by year
2026: 48 · 2025: 87 · 2024: 82 · 2023: 78 · 2022: 86 · 2021: 67 · 2020: 61
FWCI
16.88
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • National Heart, Lung, and Blood Institute (F32HL139016)
  • National Cancer Institute (U01CA228608, R35CA220449)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32HD096786)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
melanoma, metastasis, MCT1, lactate utilization, oxidative pentose phosphate pathway, reactive oxygen species, oxidative stress resistance, metabolic heterogeneity, patient-derived xenografts, isotope tracing, MCT1 inhibition, tumour cell dissemination
MeSH terms
Monocarboxylate Transport Protein 1, Animals, Cell Survival, Humans, Melanoma, Oxidative Stress, Xenograft Model Antitumor Assays, Monocarboxylic Acid Transporters, Symporters, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review